Stem Cell Therapy for Rotator Cuff Injuries: Colombia Treatment Guide

Rotator cuff injuries are among the most common causes of shoulder pain and disability, affecting an estimated 2 million Americans annually. Partial tears — where the tendon is damaged but not completely severed — present a treatment dilemma: too damaged for physical therapy alone to resolve, but not necessarily requiring the long recovery of surgical repair. MSC therapy has emerged as a promising middle option for these patients, with published data showing encouraging results for partial tears.

Candidacy: Partial vs. Full Tears

The critical distinction for stem cell therapy candidacy is tear severity. Partial-thickness tears (less than 50% of tendon depth) are the strongest indication — published data shows the best pain relief and imaging improvement in this group. High-grade partial tears (50-99% of tendon depth) may benefit but outcomes are less predictable, and surgical repair becomes a stronger competing option. Full-thickness tears with retraction are not appropriate for stem cell therapy alone — these tears have lost structural continuity and require surgical reattachment.

If you are unsure of your tear classification, a recent MRI (within three to six months) with a detailed radiology report will specify tear type, size, and tendon quality. Your treating physician in Colombia will review this imaging before recommending treatment.

Treatment Protocol

Shoulder MSC therapy in Colombia typically involves a clinical evaluation with imaging review on day one, followed by the injection procedure on day two. The injection is performed under ultrasound guidance to place cells precisely at the tear site. Local anesthesia is used; general anesthesia is not required. The entire procedure takes approximately 45–60 minutes. Most patients experience mild soreness for two to three days and begin a progressive rehabilitation program within one to two weeks.

Recovery and Return to Activity

Unlike surgical rotator cuff repair (which requires immobilization in a sling for four to six weeks and six to twelve months of rehabilitation), MSC injection recovery is far less restrictive. A typical protocol allows gentle range-of-motion exercises starting at week one, progressive strengthening at weeks four to six, return to moderate activity at weeks eight to twelve, and full activity and sport at months three to four (surgeon clearance dependent).

This accelerated timeline compared to surgery is a significant advantage for working adults, athletes, and anyone who cannot afford months of immobilization and intensive rehabilitation.

Published Outcomes

Published case series on MSC therapy for partial rotator cuff tears report 70–85% of patients achieving meaningful pain reduction at 12 months, improvements in shoulder function scores (primarily the ASES and Constant scores), imaging evidence of partial healing or tear stabilization on follow-up MRI in a subset of patients, and low complication rates (injection-site soreness being the most common, resolving in days).

It is important to note that "partial healing" does not mean complete structural repair. MSC therapy may reduce the tear size, improve tendon quality, and slow further degeneration — but expecting a complete structural repair equivalent to surgery is unrealistic for most patients. The primary benefit is functional: less pain, better range of motion, delayed or avoided surgery.